Biopharmaceutical Supply Chains Distribution, Regulatory, Systems and Structural Changes Ahead
- illustrated
- London, CRC Press 2012
- 272 pages
Contents:
Early Structural Developments and the Changes Ahead
Chapter 2 Key Forces and Myths of Distribution in the BPS Supply Chain
Chapter 3 Regulatory Trends
Changes in the Hospital Environment That Impact the Life Sciences
The Case of Oncology Medicine
Recommendations for Players in the Industry
References
Back Cover
A comprehensive exploration of the massive changes in the biopharmaceutical supply chain that have occurred during the past 10 years, and predicted future trends, Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead documents the specific impacts of these changes for key players in the supply chain. Based
1439899797 9781439899793
= activities associated auto-replenishment automated Average become believe benefit better biological biopharmaceutical brand called challenge channels clinical cold companies complex compliance continue cost counterfeit Data designed developed direct dispensing distribution dose drug effect efficient emerging environment errors estimates example FIGURE Forces global GPOs growth Health healthcare hospitals impact implementation improve increased industry integrated interview inventory involved issue Italy look machines major manufacturers Medicaid Medicare medicine noted nurses occur Oncologists oncology organizations package patient payers pedigree Performance pharma pharmaceutical pharmacists pharmacy Phase physician pick Prescription problem purchasers Pyxis reduced regulations reimbursement replenishment reporting requirements retail savings serialization Solutions specialty stockouts supply SUPPLY CHAIN Trace track turns unit wholesalers
--Pharmaceutical industry--Materials management.-- Business logistics.--Business & Economics › Quality Control-- Business & Economics / Purchasing & Buying --Business & Economics / Quality Control --Medical / Pharmacology